Clinical Trial

Establishment of a Multimodal Standard Database for Inflammation-related Ophthalmopathy

Recruiting
View on ClinicalTrials.gov →
Summary
Through a systematic observational study, the intrinsic connections and patterns between the occurrence and development of common blinding retinal diseases such as diabetic retinopathy, pathological myopia, and age-related macular degeneration and the changes in fine parameters of the anterior structure of the eye are deeply explored. To achieve this goal, investigators will adopt cutting-edge multimodal imaging technology to simultaneously collect precise data from ocular surface and fundus of participants. By integrating and analyzing these multi-dimensional information from different parts of the same eye, investigators will build a high-quality and standardized ocular surface-fundus associated image database. This database not only aims to reveal potential ocular surface biomarkers that can be used for early warning or auxiliary diagnosis, but also lays a solid data foundation for the future development of artificial intelligence-assisted diagnostic tools and the establishment of a brand-new ocular surface-fundus integrated diagnosis and treatment assessment model.
Trial Details
NCT Number NCT07628946
Lead Sponsor Dan Chen
Conditions Ocular Surface Disease, Inflammatory Disease, Retinal Disease, Choroid Diseases
Enrollment 3,000 participants
Start Date 2025-11-26
Primary Completion 2030-02 (estimated)
Study Completion 2030-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-05